Discover brain health and Alzheimer’s clinical studies
We run a range of studies for people aged 50+ living with dementia or mild cognitive impairment and those who may be concerned about changes happening to their memory.
Each study has its own purpose and eligibility criteria, but all share one goal — to improve understanding and treatment of neurodegenerative brain diseases that cause dementia.
We match people to studies based on the eligibility criteria.
Studies and trials currently recruiting
IONA Observational Study (Scottish Brain Sciences study)
The IONA Longitudinal Cohort Study is our own observational study exploring risk factors and early signs of conditions that can lead to dementia.
- Who we’re looking for:
- People aged 50+ with a diagnosis of brain condition causing dementia or mild cognitive impairment
- People aged 55+ with concerns about recent changes their memory which may be impacting daily life
- People aged 90 + with no cognitive concerns
- Type of study : Observational with baseline and annual biomarker and cognitive testing.
- Length of study: 10 years with an annual visit and 6 monthly telephone check-in.
- Location: Available in Aberdeen and Edinburgh.
Disease-modifying treatments which may help slow disease progression of Alzheimer’s disease dementia.
- Who we’re looking for: People aged 50-90 with a diagnosis of Mild Cognitive Impairment or Early Alzheimer’s Disease.
- Type of study: An intervention study with regular infusions of the study drug or placebo.
- Location: Available in Aberdeen and Edinburgh.
Treatment which may help manage agitation symptoms associated with Alzheimer’s disease dementia.
- Who we’re looking for: People aged 55-90 with a diagnosis of Alzheimer’s who experience agitation as a symptom. Agitation can include a range of behaviours including pacing or wandering, repetitive actions or aggression.
- Study design: Study drug or placebo taken as a daily capsule over 8 weeks.
- Location: Open in Aberdeen and Edinburgh.
Treatment to prevent or delay onset of Alzheimer’s disease symptoms in those with no current symptoms or diagnosis.
Eligibility is determined by detection of the early changes that lead to Alzheimer’s disease.
- Who we’re looking for:
- People aged 65-80 with no diagnosis of Alzheimer’s disease
- People aged 55-64 with a parent or sibling with a diagnosis of Alzheimer’s Disease or are known to possess at least one copy of the APOE4 gene
- Type of study: Study drug or placebo given through regular infusions.
- Location: Open in Aberdeen and Edinburgh.
All our studies are approved by an independent ethics committee and conducted under strict NHS and UK regulatory standards.
Your safety, privacy, and comfort always come first.
Want to learn more?
Join hundreds of people who are already making a difference in Alzheimer’s and brain health research.
